BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 3218263)

  • 21. Horseshoe kidney with mesangioproliferative glomerulonephritis and goiter.
    Kavukçu S; Sahin B; Türkmen M; Soylu A; Lebe B; Büyükgebiz A
    Turk J Pediatr; 2003; 45(4):350-2. PubMed ID: 14768805
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lupus nephritis: clinical course in relation to treatment.
    Nanra RS; Kincaid-Smith P
    Perspect Nephrol Hypertens; 1973; 1 Pt 2(0):1193-210. PubMed ID: 4803309
    [No Abstract]   [Full Text] [Related]  

  • 23. A patient with membranoproliferative glomerulonephritis diagnosed by the third biopsy via endocapillary proliferative glomerulonephritis and focal membranoproliferative glomerulonephritis.
    Kano K; Nishikura K; Kojima M; Yamada Y; Arisaka O; Tomita S; Shimotsuji T; Fujikawa Y; Inafuku S; Imakita M; Ueda Y
    Clin Exp Nephrol; 2003 Jun; 7(2):157-62. PubMed ID: 14586735
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Excretion of glycosaminoglycans in the urine--a marker for the activity of mesangioproliferative glomerulonephritis.
    Deliyska B; Shurliev V; Nikolov D; Tishkov I
    Nephrol Dial Transplant; 1997 Sep; 12(9):2033. PubMed ID: 9306374
    [No Abstract]   [Full Text] [Related]  

  • 25. The impact of sex in primary glomerulonephritis.
    Cattran DC; Reich HN; Beanlands HJ; Miller JA; Scholey JW; Troyanov S;
    Nephrol Dial Transplant; 2008 Jul; 23(7):2247-53. PubMed ID: 18182409
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of pulse and oral steroid in childhood membranoproliferative glomerulonephritis.
    Bahat E; Akkaya BK; Akman S; Karpuzoglu G; Guven AG
    J Nephrol; 2007; 20(2):234-45. PubMed ID: 17514629
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Surgical treatment of renovascular hypertension: a 10-year review.
    Morin JE; Ralphs S; Skinner GB
    Can J Surg; 1980 Jul; 23(4):334-5. PubMed ID: 6998549
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Immunological studies of the mechanism of the therapeutic action of azathioprine and of indomethacin in chronic active glomerulonephritis and the nephrotic syndrome].
    Campanacci L; Castellani A; Gambari PF; Huber W; Fagiolo U; Vesco F; Contini MG; Rebecca L
    Minerva Nefrol; 1970; 17(4):127-50. PubMed ID: 4102147
    [No Abstract]   [Full Text] [Related]  

  • 29. Membranoproliferative glomerulonephritis type II in a 10-year-old girl.
    Tibbs ME; Andreoli SP; Phillips CL
    Clin Lab Sci; 2005; 18(2):84-9. PubMed ID: 15916240
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Decrease of mesangial matrix after immunosuppressive therapy in children with reversible membranoproliferative glomerulonephritis type I.
    Inaba S; Tanizawa T; Takahashi T; Ishihara S; Arai M; Sakai Y; Kurose KK; Matsukura H; Okada T
    Clin Nephrol; 1996 Apr; 45(4):217-25. PubMed ID: 8861795
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Steroid and azathioprine versus steroid, cyclosporine, and azathioprine therapies in primary haplo-identical living donor kidney transplantation: twenty-year experience.
    Gheith OA; Bakr MA; Fouda MA; Shokeir AA; Bayoumy A; Sobh M; Ghoneim M
    Iran J Kidney Dis; 2008 Jan; 2(1):34-9. PubMed ID: 19367007
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Polymorphism studies of angiotensin converting enzyme gene in chronic glomerulonephritis].
    Kutyrina IM; Tareeva IE; Nosikov VV; Kamyshova ES; Gorashko NM; Chistiakov DA; Okonova EB; Troepol'skaia OV
    Ter Arkh; 1999; 71(6):30-4. PubMed ID: 10420452
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of aldosterone in left ventricular hypertrophy in hypertension.
    Matsumura K; Fujii K; Oniki H; Oka M; Iida M
    Am J Hypertens; 2006 Jan; 19(1):13-8. PubMed ID: 16461184
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Possibilities for treating patients with the idiopathic nephrotic syndrome].
    Belovezhdov N
    Vutr Boles; 1985; 24(4):55-63. PubMed ID: 4072170
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The relationship between kynurenine, catecholamines, and arterial hypertension in mesangioproliferative glomerulonephritis.
    Martinsons A; Rudzite V; Jurika E; Silava A
    Adv Exp Med Biol; 1996; 398():417-9. PubMed ID: 8906298
    [No Abstract]   [Full Text] [Related]  

  • 36. [Treatment of intracapillary-proliferative glomerulonephritis].
    Lemke E; Fröhling P; Metz EG
    Z Urol Nephrol; 1978 Jun; 71(6):385-90. PubMed ID: 685515
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Treatment of glomerulonephritis].
    Lison AE
    Verh Dtsch Ges Inn Med; 1989; 95():581-6. PubMed ID: 2690528
    [No Abstract]   [Full Text] [Related]  

  • 38. Remission of membranoproliferative nephritis with angiotensin converting enzyme inhibition and receptor blockade.
    Butani L
    Pediatr Nephrol; 2003 Nov; 18(11):1199. PubMed ID: 13680333
    [No Abstract]   [Full Text] [Related]  

  • 39. Cutaneous telangiectasias, sparse hair, and type I membranoproliferative glomerulonephritis.
    Gupta IR; Tsai CH; Siegel-Bartelt J; Thorner P; Balfe JW
    Pediatr Nephrol; 1999 Feb; 13(2):129-31. PubMed ID: 10228999
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term follow-up of juvenile acute nonproliferative glomerulitis (JANG).
    Fujita T; Nozu K; Iijima K; Kamioka I; Kaito H; Tanaka R; Nakanishi K; Matsuo M; Yoshikawa N
    Pediatr Nephrol; 2007 Nov; 22(11):1957-61. PubMed ID: 17674054
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.